Acadia Pharmaceuticals Inc (ACAD)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Stephen R. Davis |
| Employees: | 510 |
| Web site: | acadia-pharm.com |
|
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
858-558-2871
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
ACADIA Pharmaceuticals Inc. focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
Please log in first to see chart